SSX2B Activators
The chemical class termed SSX2B Activators is a group of compounds that might influence the activity of SSX2B indirectly through their impact on various cellular processes and pathways associated with development and progression. SSX2B, being implicated in sarcoma, is subject to the complex interplay of signaling pathways that govern cell proliferation, DNA damage response, and apoptosis.
Compounds like 5-Fluorouracil, Doxorubicin, and Cisplatin, well-known chemotherapy agents, induce DNA damage and cellular stress, potentially impacting the cellular context in which SSX2B operates. By influencing DNA repair mechanisms and cellular stress responses, these agents could indirectly modulate SSX2B activity, particularly in cancer cells where SSX2B is aberrantly expressed or functional. Similarly, Methotrexate and Paclitaxel, by disrupting DNA synthesis and microtubule dynamics, respectively, could also alter the cellular environment in a manner that impacts SSX2B activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
AN agent that induces DNA damage. It could potentially influence cellular stress pathways, indirectly affecting SSX2B activity in cells. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A chemotherapy drug that stabilizes microtubules. It could potentially induce cellular stress and affect SSX2B activity in the context of research. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
An anthracycline known to induce DNA damage, potentially influencing SSX2B activity in cells. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, affecting DNA synthesis. It could indirectly influence pathways related to SSX2B activity in cells. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A platinum-based chemotherapy drug that causes DNA crosslinking. This could potentially influence SSX2B activity by affecting DNA repair mechanisms in cancer cells. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
A selective estrogen receptor modulator. While its primary action is on estrogen receptors, it could influence pathways that indirectly affect SSX2B activity in hormone-responsive. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
A tyrosine kinase inhibitor studied in the research. It could potentially influence signaling pathways that indirectly affect SSX2B activity in cells. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor potentially influence protein degradation pathways, indirectly affecting SSX2B activity. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An epidermal growth factor receptor inhibitor used in potentially modulate signaling pathways that indirectly influence SSX2B activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A kinase inhibitor affect various signaling pathways, potentially influencing SSX2B activity indirectly. | ||||||